<DOC>
	<DOCNO>NCT02129348</DOCNO>
	<brief_summary>Clinically , many patient AD show response minimal response antipsychotic symptoms agitation/aggression psychosis , intolerable side effect medication . Antipsychotics wide range side effect , include risk increase mortality ( 60-70 % high rate death antipsychotic compare placebo ) lead FDA black box warn patient dementia ; recent review meta-analysis show 54 % increase risk mortality . In addition , patient show partial response antipsychotic symptom persist . For reason , investigator need study alternative treatment strategy . Currently , FDA-approved medication treatment psychosis agitation AD . The investigator innovative project examine efficacy side effect low dose lithium treatment agitation/aggression without psychosis 80 patient AD randomize , doubleblind , placebo-controlled , 12-week trial ( essentially Phase II trial ) . The result determine potential large-scale clinical trial ( Phase III ) establish utility lithium patient .</brief_summary>
	<brief_title>Treatment Psychosis Agitation Alzheimer 's Disease</brief_title>
	<detailed_description>Symptoms psychosis agitation common Alzheimer 's disease . These symptom associate distress patient , increase burden caregiver , rapid cognitive decline , great risk institutionalization mortality , increase health care cost . In recent meta-analysis , caregiver education behavior modification study reveal small medium effect size treat agitation patient . However , none study double-blind ( difficult achieve study ) none control group receive amount staff time intervention group , thereby bias result toward active intervention . Among psychotropic medication study , antipsychotic show superiority placebo treatment psychosis agitation patient dementia . However , study show moderate superiority antipsychotic placebo study negative . The side effect antipsychotic medication include sedation , extrapyramidal sign , tardive dyskinesia , weight gain , metabolic syndrome . A pooled analysis 17 short-term trial show mortality rate patient dementia receive antipsychotic medication 1.6 1.7 time high ( 60-70 % increase mortality rate ) mortality rate patient receive placebo . These finding lead FDA issue black-box warn antipsychotic medication use patient dementia ; recent meta-analysis report slightly low odds ratio 1.54 ( 54 % increase mortality rate ) . Lithium several different action anticonvulsant , though effective bipolar disorder , especially mania . Lithium propose treat mania AD though investigator monitor symptom Young Mania Rating Scale . In patient AD , lithium study putative cognitive enhancing effect . A report suggest chronic lithium use reduces risk dementia , data show increased dementia risk lithium use . A placebo-controlled , single-blind lithium trial show cognitive effect patient AD , recent trial lithium 45 patient mild cognitive impairment ( MCI , often lead clinically diagnosable AD ) show small advantage lithium ( n=24 ) placebo ( n=21 ) attention cognitive domain . None study lithium intend treat psychosis agitation AD , patient symptoms typically excluded clinical trial . There systematic placebo-controlled trial lithium treat agitation/aggression without psychosis AD even though lithium highly effective treatment mania psychosis symptom agitation aggression . Nonetheless , publish study lithium treat cognitive decline old patient show low-dose lithium safe patient MCI AD . Specific Aims Hypotheses Specific Aim 1 . To compare change agitation/aggression without psychosis patient AD receive 12 week randomize , double-blind treatment lithium placebo . Primary Hypothesis . Over 12 week , agitation/aggression domain score Neuropsychiatric Inventory ( NPI ) decrease significantly lithium placebo . Secondary Hypothesis . Over 12 week , proportion responder lithium significantly great proportion responder placebo . Response define 30 % decrease NPI core score ( define sum domains agitation/aggression , delusion hallucination ) plus CGI Change score much improve much improve ( CGI base behavioral symptom ) . Exploratory hypothesis . Over 12 week , psychosis score , measure sum NPI domain score delusion hallucination , decrease significantly lithium placebo . Specific Aim 2 . To evaluate tolerability low dose lithium assess emergent somatic side effect course 12-week trial lithium compare placebo . Specific Aim 3 . To explore association improvement lithium ( decrease agitation/aggression psychosis score ) serum brain-derived neurotrophic factor ( BDNF ) level ( baseline , 12 week ) , SNP intron 1 ACCN1 gene , variation 7q11.2 gene locus , index associate lithium response bipolar disorder . The investigator postulate specific mechanism action lithium investigator trial , evaluate three potential predictor lithium response aim improve patient selection personalize treatment . The investigator examine BDNF serum level biomarker correlate lithium treatment correlate change BDNF level change NPI agitation/aggression psychosis score .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>1 . Age 5595 year 2 . Diagnosis possible probable AD standard NIA criterion ( McKahnn et al , 1984 ; McKhann et , 2011 ) 3 . Folstein MMSE 526 30 4 . Neuropsychiatric Inventory ( NPI ) agitation/aggression subscale score &gt; 4 . On subscale ( frequency X severity ) , score high 4 represent moderate severe symptom . 5 . Female patient need postmenopausal 6 . Availability informant ; patient without informant recruit . Patients lack capacity must surrogate . 1 . Medical contraindication lithium treatment prior history intolerability lithium treatment . Contraindications lithium study include : rest tremor cause functional impairment , history fall last month , untreated thyroid disease abnormal thyroid function test ( T3 , T4 , TSH ) , creatinine level great 1.5 mg/100ml glomerular filtration rate le 44ml/min/ 1.73m2 ; blood pressure &gt; 150/90 mm Hg ; heart rate &lt; 50 bpm ; unstable cardiac disease base history , physical examination , ECG . 2 . Medications , combination lithium , know adverse renal effect , include therapeutic high dos diuretic , i.e . hydrochlorothiazide great 25mg daily furosemide great 10mg daily . Whenever feasible , patient receive concomitant antidepressant antipsychotic wash medication least 24 hour start lithium . Patients wish discontinue antipsychotic antidepressant , typically family member/caregiver objection , allow enter trial provide contraindication concomitant lithium use specific psychotropic medication . During trial , patient permit receive lorazepam need 2 mg/day anxiety/insomnia , nonbenzodiazepine hypnotic , e.g. , zolpidem . 3 . Current clinical diagnosis schizophrenia , schizoaffective disorder , psychosis , bipolar 1 disorder ( DSMIV TR criterion ) . 4 . Current recent ( past 6 month ) alcohol substance dependence ( DSMIV TR criterion ) . 5 . Current major depression suicidality assess study psychiatrist . 6 . Suicidal behavior dangerous behavior serious safety risk risk physical harm self others . 7 . Parkinson 's disease , Lewy body disease , multiple sclerosis , CNS infection , Huntington 's disease , amyotrophic lateral sclerosis , major neurological disorder . 8 . Clinical stroke residual neurological deficit . MRI find cerebrovascular disease ( smallinfarcts , lacunes , periventricular disease ) absence clinical stroke residual neurological deficit lead exclusion . 9 . Acute , severe , unstable medical illness . For cancer , patient active illness metastasis exclude , past history successfully treat cancer lead exclusion . 10 . QTc interval &gt; 460 ms time baseline EKG exclusion criterion treatment .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>psychosis</keyword>
	<keyword>agitation</keyword>
	<keyword>aggression</keyword>
	<keyword>Lithium</keyword>
	<keyword>delusion</keyword>
	<keyword>hallucination</keyword>
</DOC>